Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0938
+0.0013 (1.36%)
At close: Dec 5, 2025
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $41.42 million as of December 5, 2025. Its market cap has increased by 228.05% in one year.
Market Cap
41.42M
Enterprise Value
53.91M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 41.42M, an increase of 353.01%. That is a compound annual growth rate of 25.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 561.91M |
| Glass House Brands | 513.14M |
| CytoDyn | 403.93M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 363.73M |
| Silence Therapeutics | 328.75M |
| Nika Pharmaceuticals | 259.91M |